Lead, US Hematology Pipeline Commercialization

Pursue Progress, Discover Extraordinary

Better is out there. Better medications, better outcomes, better science. But progress doesn't happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let's be those people.

At Sanofi, we provide equal opportunities to all regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, ability or gender identity.

Watch our ALL IN video and check out our Diversity Equity and Inclusion actions at !

US and Puerto Rico Residents Only

Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally inclusive and diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; natural or protective hairstyles; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation;

disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.

North America Applicants Only

The salary range for this position is: $ - $. All compensation will be determined commensurate with demonstrated experience. Employees may be eligible to participate in Company employee benefit programs. Additional benefits information can be found through the LINK.

Location:

Cambridge, MA

Sanofi Specialty Care has pioneered the development and delivery of transformative therapies for patients affected by debilitating diseases for more than 30 years. We achieve this through world-class science, close collaboration with the global patient community, and the compassion and commitment of our employees.

Within Sanofi Specialty Care, the US Rare Blood Disorders franchise is committed to advancing care for patients with complex hematologic and immunologic conditions. The franchise has a diverse and rapidly growing portfolio, including industry-leading products in hemophilia; the first and only approved medicines in acquired thrombotic thrombocytopenic purpura and indolent and advanced systemic mastocytosis, Cablivi and Ayvakit, respectively; and now expanding rapidly to other under-served hematologic disorders with the launch of Wayrilz in Immune Thrombocytopenia (ITP).

The Lead, US Hematology Pipeline Commercialization will serve as the US commercial architect for future Wayrilz indications.

This role will have primary responsibility for shaping the US commercial strategy, market development approach, investment plan, and launch readiness for Wayrilz in warm Autoimmune Hemolytic Anemia (wAIHA) and sickle cell disease. This role will also contribute to the US commercialization strategy for Wayrilz in IgG4-related disease and help evaluate additional future indications and opportunities.

The successful candidate will rapidly build a deep understanding of patients, providers, treatment pathways, market dynamics, and emerging competition. They will translate incomplete and evolving information into clear strategic choices and help define what must be true for future indications to succeed in the US market.

This role requires strong strategic judgment, executive presence, commercial acumen, and the ability to lead through influence in a highly matrixed environment.

The role reports to the Head of Rare Hematology Marketing and will work closely with the US ITP Marketing Lead, the Global Wayrilz team, and other cross-functional leaders.

What Success in Role Looks Like

The successful candidate will ensure that future hematology indications are shaped with the US market in mind from the earliest stages of development. They will create clear and differentiated commercial strategies, influence evidence and investment decisions, build organizational alignment, and establish strong launch…